PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
06-Mar-2024 FDA Clears Beckman Coulter Life Sciences DxFLEX Flow Cytometer Beckman Coulter Life Sciences
06-Mar-2024 Jemperli▼ (dostarlimab) becomes the first immunotherapy treatment to receive NICE recommendation for use, in line with its license, in eligible endometrial cancer patients in first line setting GSK
05-Mar-2024 ADARE PHARMA SOLUTIONS TO EXPAND PACKAGING & WAREHOUSING CAPABILITIES IN EUROPE Adare Pharma Solutions
05-Mar-2024 The York Health Economic Consortium will undertake the first UK health economic analysis of Ondine’s Steriwave light-activated antimicrobial to reduce Surgical Site Infections York Health Economics Consortium (YHEC)
05-Mar-2024 Ariceum Therapeutics announces opening of new state-of-the-art laboratory in Berlin providing infrastructure for radiopharmaceutical development activities Ariceum Therapeutics
05-Mar-2024 Fibrocor Therapeutics enters into research and development collaboration with McQuade Center for Strategic Research and Development to advance Alport Syndrome program Fibrocor Therapeutics Inc
05-Mar-2024 Alcidion launches Miya Results Tracking in response to patient safety challenge Alcidion Group Limited
05-Mar-2024 Transgene, NEC and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050 Transgene
05-Mar-2024 Lundbeck presents encouraging results from the Lu AF82422 trial for Multiple System Atrophy at the international AD/PD 2024 conference on neurodegenerative disorders Lundbeck A/S
05-Mar-2024 ViiV Healthcare presents phase I clinical trial findings of a cabotegravir long-acting injectable investigational formulation allowing at least four months between doses ViiV Healthcare
05-Mar-2024 CluePoints’ Audit Trail Review Project Wins Award for Innovation in the Management of Clinical Data Award CluePoints
28-Feb-2024 Avance Clinical CEO Talks with SCRIP about US Biotech Sector "Green Shoots" and a New CRO Report Avance Clinical
27-Feb-2024 PureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan PureTech Health plc
27-Feb-2024 Curve Therapeutics raises £40.5 million to turbocharge discovery platform and advance breakthrough pipeline Curve Therapeutics
27-Feb-2024 CellProthera collaborates with Japanese stem cell experts at Shonan-Kamakura General Hospital (SKGH) on clinical manufacturing for upcoming autologous stem cell trials in ischemic diseases CellProthera
27-Feb-2024 Dr. Pfleger Arzneimittel Scales Digital Field Engagement with Veeva Commercial Cloud Veeva
27-Feb-2024 PureTech to Present at Two Upcoming Investor Conferences PureTech Health
27-Feb-2024 Key Insights from the DACH Healthcare Innovation Summit: More Collaboration, Interoperability, and Technology to Enhance Healthcare Systems Response Bamberg Health
26-Feb-2024 BeiGene Receives Positive CHMP Opinion for Tislelizumab as Treatment for Non-Small Cell Lung Cancer BeiGene
26-Feb-2024 MANDARA Phase III data published in New England Journal of Medicine show remission is an achievable goal in eosinophilic granulomatosis with polyangiitis (EGPA) with Fasenra AstraZeneca